The Efficacy and Safety of Intermittent Low-Dose Urokinase Thrombolysis for the Treatment of Senile Acute Intermediate-High-Risk Pulmonary Embolism: A Pilot Trial

Thrombolysis and anticoagulation were the main treatment methods for acute pulmonary embolism. However, the use of thrombolysis drugs may lead to bleeding complications. We compared intermittent low-dose urokinase (UK) and alteplase (recombinant tissue plasminogen activator [rt-PA]) in normotensive...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Tianming, Ni, Jixiang, Hu, Xuehua, Wang, Yingnan, Du, Xinge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714758/
https://www.ncbi.nlm.nih.gov/pubmed/29552916
http://dx.doi.org/10.1177/1076029618758953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714758/
https://www.ncbi.nlm.nih.gov/pubmed/29552916
http://dx.doi.org/10.1177/1076029618758953

Ejemplares similares